All persons or entities that purchased the publicly-traded securities listed on United States stock exchanges of Akari Therapeutics, plc (“Akari” or the “Company”) during the period from April 24, 2017 through May 30, 2017, both dates inclusive
Disbursed
April 23, 2017 - August 25, 2017
November 28, 2018
November 07, 2018
Strategic Claims Services
Akari Therapeutics, plc. Securities Litigationc/o Strategic Claims ServicesP.O. Box 230600 N. Jackson St., Ste. 205Media, PA 19063
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.